Draxxin is indicated for the treatment and prevention of Bovine Respiratory Disease associated with Mannheimia haemolytica, Pasturella multocida, Histophilus somni and Mycoplasma bovis.
Draxxin is also indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated wit Moraxella bovis.
Dose rate: 1ml/40 kg
Meat: 22 days
Milk: Do not use in lactating cattle producing milk for human consumption. Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition.
You are now leaving the regional website to access another site in the group.
Regulatory constraints and medical practices vary across regions from market to market. Consequently, the information provided on the site in which you enter may not be suitable for use in your region.